A first-in-human study of a new drug in healthy Chinese and Japanese adults
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 18 to 60.
- You have Chinese or Japanese ancestry (born in China, Hong Kong, Taiwan, Macau, or Japan, with both parents and all four grandparents from those regions).
- Your weight and body mass index (BMI) are within a certain range (BMI 18.0 to 30.0).
- You are in good general health, with no serious medical conditions, infections, or abnormal heart or kidney function.
- You have not used tobacco, certain medications, or illicit drugs recently, and you do not have a history of alcohol abuse or certain psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.
This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.